TY - JOUR
T1 - Hepatitis C virus treatment
T2 - Simplifying the simple and optimizing the difficult
AU - Falade-Nwulia, Oluwaseun
AU - Sulkowski, Mark S.
N1 - Publisher Copyright:
© 2020 The Author(s) 2020.
PY - 2020/12/15
Y1 - 2020/12/15
N2 - The availability of safe, efficacious, oral direct-acting antivirals (DAAs) have ushered in a new era of hepatitis C treatment with potential to eliminate hepatitis C as a public health threat. To achieve population-level effectiveness of these oral DAAs, hepatitis C treatment by a wide range of providers in different settings will be essential to increase the number of persons treated. We provide a clinical review of hepatitis C treatment with a focus on practical tools for management of hepatitis C in majority of currently infected individuals who can be easily cured and optimization of treatment for those in whom treatment may not be as simple.
AB - The availability of safe, efficacious, oral direct-acting antivirals (DAAs) have ushered in a new era of hepatitis C treatment with potential to eliminate hepatitis C as a public health threat. To achieve population-level effectiveness of these oral DAAs, hepatitis C treatment by a wide range of providers in different settings will be essential to increase the number of persons treated. We provide a clinical review of hepatitis C treatment with a focus on practical tools for management of hepatitis C in majority of currently infected individuals who can be easily cured and optimization of treatment for those in whom treatment may not be as simple.
KW - Hepatitis C
KW - Oral direct-acting antivirals
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85096949046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096949046&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiaa534
DO - 10.1093/infdis/jiaa534
M3 - Article
C2 - 33245350
AN - SCOPUS:85096949046
SN - 0022-1899
VL - 222
SP - S745-S757
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
ER -